Treatment of Teeth Grinding (Bruxism)
Start with conservative, reversible approaches: patient education and behavioral strategies, combined with an occlusal appliance (bite plate/splint) for tooth protection, particularly for nocturnal bruxism. 111
First-Line Management Algorithm
Immediate Protection
- Provide an occlusal appliance (bite plate/splint) for nocturnal bruxism to prevent dental damage and reduce grinding sounds 112
- This is the most evidence-based protective measure, though effects on reducing actual muscle activity are transient 2
- Primary goal is tooth protection, not elimination of bruxism itself
Behavioral and Conservative Interventions
The 2023 BMJ guidelines emphasize starting with these reversible approaches 11:
Patient education and reassurance about the condition
Behavioral modification strategies:
Cognitive behavioral therapy (CBT) - particularly effective for awake bruxism 113
Adjunctive Physical Therapies
Pharmacologic Options (Second-Line)
Important caveat: Current evidence shows pharmacotherapy provides limited short-term benefits at best and should NOT replace first-line approaches 4. The 2026 systematic review found overall certainty of evidence ranging from low to very low 4.
When to Consider Medications
Only after conservative measures have been attempted, and primarily for:
- Severe cases with significant pain or functional impairment
- Presence of psychiatric comorbidities 2
- Secondary bruxism from neurological conditions 2
Specific Agents (in order of evidence quality):
For symptomatic relief:
For refractory cases with comorbidities:
- Clonidine showed the most consistent (though modest) reduction in bruxism frequency 4
- Tricyclic antidepressants (e.g., amitriptyline) for chronic pain and sleep issues 11
- Gabapentin reduced rhythmic masticatory muscle activity and improved sleep efficiency in limited studies 14
- Clonazepam may improve sleep bruxism in patients with psychiatric/sleep comorbidities, but lacks robust trial evidence 2
Agents with insufficient evidence:
- Benzodiazepines, dopaminergic agents, and beta-blockers showed no reproducible benefit 4
Specialized Interventions
Botulinum Toxin
- Reserve for severe secondary bruxism interfering with speaking, chewing, or swallowing 2
- Particularly useful in cranial dystonia or neurological disorders 2
- Effects last 1-5 months 2
- Reduces subjective complaints and improves mandibular function 5
- Concerns exist regarding possible adverse effects with repeated use 6
Acupuncture
Critical Pitfalls to Avoid
- Never perform irreversible occlusal adjustments - these have no evidence basis and are explicitly recommended against 1
- Do not rely on pharmacotherapy alone - it should never replace behavioral strategies and occlusal appliances 4
- Distinguish between sleep and awake bruxism - management strategies differ 23
- Awake bruxism responds better to behavioral/CBT approaches 3
- Sleep bruxism requires protective appliances as primary intervention
- Screen for underlying conditions:
Key Clinical Considerations
The fundamental principle: Bruxism itself does not require treatment unless it causes problems (tooth damage, pain, functional impairment) 6. The goal is managing consequences, not eliminating the behavior entirely.
Patient engagement is essential - all effective interventions require active patient participation 1. Discuss adherence expectations upfront, particularly for behavioral strategies and consistent appliance use.
Multidisciplinary approach may be needed for complex cases involving significant psychological comorbidities, chronic pain, or neurological conditions 12.